Home/Brenus Pharma/Paul Bravetti

PB

Paul Bravetti

Chief Executive Officer (CEO)

Therapeutic Areas

Oncology Immunology

Brenus Pharma Pipeline

Drug	Indication	Phase
STC-1010	Unresectable metastatic Microsatellite Stable (MSS) Colorectal Cancer (1L)	Phase 1/2
Undisclosed Candidate	Not Specified	Pre-clinical

Leadership Team at Brenus Pharma

Jacques Gardette

Co-founder, President

Co-founder, Chief Scientific Officer (CSO)

Corinne Tortorelli

Senior Medical Affairs & Clinical Development Lead

Alexander Eggermont

Lead Clinical Advisor

View full Brenus Pharma profile